title: Importance of surgical resection in the successful management of soft tissue sarcoma.
abstract: OBJECTIVE
  A systemic disease-free state necessitates a local disease-free state. This cannot be accomplished without a properly performed resection by an experienced surgical team. Successful local management of soft tissue sarcoma (STS) may lead to improved disease-free survival. An STS treatment protocol using wide local excision followed by radiation therapy is effective in achieving local tumor control and survival similar to that of multiple-modality regimens, but with lower morbidity.
  
  
  METHODS
  Retrospective cohort review (August 1, 1987, to May 6, 1998).
  
  
  METHODS
  Referral to a single musculoskeletal oncologic surgeon, with surgery performed at a tertiary care medical center in a large urban area.
  
  
  METHODS
  Ninety patients with STS of the trunk or extremities.
  
  
  METHODS
  Preoperative evaluation included surveillance computed tomographic scan of the chest, magnetic resonance imaging of primary site to assess tumor extent and to plan the surgical approach, and angiography if vascular bypass was proposed. Wide local excision of tumor was performed, with concomitant vascular bypass and/or complex plastic reconstruction as needed. Postoperative radiation therapy was given in most patients. Adjuvant chemotherapy was used selectively.
  
  
  METHODS
  Morbidity, local recurrence rates, and survival.
  
  
  RESULTS
  Histologically negative margins were obtained in 89 (99%) of 90 patients; 86 (96%) remained free of local disease at follow-up. Five patients died of systemic metastatic disease.
  
  
  CONCLUSIONS
  Excellent local control obtained with aggressive, appropriate surgery followed by radiation therapy in most patients and chemotherapy in only selective high-risk patients leads to excellent survival, with low morbidity and good functional outcome.
authors.affiliation: Department of Orthopedic Surgery, Swedish Medical Center, Seattle, Wash., USA. dflugs9514@aol.com
authors.forename: D L
authors.initials: DL
authors.lastname: Flugstad
authors.forename: C P
authors.initials: CP
authors.lastname: Wilke
authors.forename: M A
authors.initials: MA
authors.lastname: McNutt
authors.forename: R A
authors.initials: RA
authors.lastname: Welk
authors.forename: M J
authors.initials: MJ
authors.lastname: Hart
authors.forename: W C
authors.initials: WC
authors.lastname: McQuinn
mesh_terms: D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D012189:Retrospective Studies; D012509:Sarcoma / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D016896:Treatment Outcome